×
About 106,110 results

ALLMedicine™ Immunodeficiency Center

Research & Reviews  51,511 results

Seroprevalence and trends of transfusion transmissible infections among retrospective b...
https://doi.org/10.1016/j.transci.2021.103132
Transfusion and Apheresis Science : Official Journal of T... Emadi B, Ghahraman Rezaieh M et. al.

Apr 13th, 2021 - Transfusion transmissible infections (TTIs) have been a public health challenge for the accessibility, quality and safety of blood transfusion. The present study aimed to consider the prevalence and the trends of hepatitis B virus (HBV), hepatitis...

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV...
https://doi.org/10.1080/22221751.2021.1917309
Emerging Microbes & Infections; Yu D, Zhu Y et. al.

Apr 13th, 2021 - EK1 peptide is a membrane fusion inhibitor with broad-spectrum activity against human coronaviruses (CoVs). In the outbreak of COVID-19, we generated a lipopeptide EK1V1 by modifying EK1 with cholesterol, which exhibited significantly improved ant...

The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preec...
https://doi.org/10.1007/s11906-021-01138-5 10.1007/s10096-020-03899-4 10.1038/s41591-020-0820-9 10.1002/jmv.25732 10.1016/j.hlc.2014.01.001 10.1038/nrg2290 10.1016/j.cell.2007.12.024 10.1152/physrev.00041.2015 10.1177/0300985813502820 10.1038/nm1639 10.1161/01.Hyp.0000060689.38912.Cb 10.1186/gb-2007-8-2-r27 10.1002/path.2162 10.1016/j.bpobgyn.2011.01.006 10.7189/jogh.08.020401 10.1161/hypertensionaha.117.10803 10.1016/S0140-6736(05)17987-2 10.1146/annurev-pathol-121808-102149 10.1155/2018/8724549 10.1002/ijgo.12038 10.1016/j.ejogrb.2004.04.014 10.1016/j.jri.2007.04.005 10.5830/cvja-2012-078 10.1038/s41564-020-0688-y 10.1002/cbic.202000047 10.1016/j.cmi.2020.04.010 10.1016/j.scitotenv.2020.141364 10.1001/jama.2020.1585 10.1128/jvi.00127-20 10.1016/j.molcel.2020.04.022 10.1038/s41467-020-15562-9 10.1056/NEJMoa1910993 10.1042/cs20200163 10.29252/rbmb.9.1.97 10.3389/fendo.2013.00166 10.1002/cphy.c130040 10.1016/j.biochi.2020.04.008 10.1161/circresaha.116.307708 10.1016/j.placenta.2011.09.020 10.1016/j.placenta.2010.01.006 10.1210/jcem.87.4.8422 10.1016/j.placenta.2005.02.015 10.1152/ajprenal.00410.2003 10.1139/y87-391 10.1172/jci107462 10.1385/endo:18:3:239 10.1385/endo:16:2:117 10.1038/s41371-018-0113-7 10.1161/circresaha.118.313276 10.1056/NEJMoa055352 10.3389/fmed.2019.00010 10.1016/S0021-9258(18)41732-2 10.1016/j.ajog.2015.08.003 10.1002/pd.2660 10.1016/j.drudis.2018.01.048 10.1007/s10815-018-1326-y 10.1172/jci22991 10.1016/j.ebiom.2015.09.003 10.1016/j.fertnstert.2014.01.058 10.5935/1518-0557.20160039 10.1095/biolreprod.113.116590 10.1038/srep40001 10.1371/journal.pone.0041080 10.1161/circresaha.118.313276 10.1186/1471-2164-8-166 10.1373/clinchem.2010.147660 10.1093/molehr/gaz010 10.1017/s204017441900014x 10.1161/CIRCULATIONAHA.111.054361 10.1016/j.ajpath.2011.04.035 10.1038/cmi.2014.45 10.1016/j.bbcan.2009.09.005 10.1161/circresaha.108.191270 10.1096/fj.09-149724 10.1016/j.ejmhg.2015.03.006 10.6515/acs20170221b 10.1371/journal.pone.0084188 10.1016/j.cjca.2014.12.026 10.1161/hypertensionaha.111.203489 10.1042/cs20120121 10.1038/srep19910 10.1016/j.devcel.2008.07.008 10.1161/01.Res.0000265065.26744.17 10.1371/journal.pone.0090020 10.3892/mmr.2014.2214 10.1161/hypertensionaha.112.197301 10.1016/j.placenta.2012.07.012 10.3389/fcvm.2017.00060 10.1111/j.1582-4934.2011.01291.x 10.1530/rep-09-0092 10.1152/physiol.00043.2008 10.1177/0300060514540627 10.1111/febs.12037 10.1210/jc.2011-3131 10.1210/jc.2017-00672 10.1016/s0140-6736(15)00070-7 10.1371/journal.pone.0170063 10.1016/s0140-6736(02)11195-0 10.1016/j.jinf.2013.12.018 10.1097/01.aids.0000198090.70325.bd 10.3389/fimmu.2019.03079 10.1007/s11262-017-1443-1 10.1186/s12985-019-1128-6 10.1128/jvi.05065-11 10.1371/journal.ppat.1000263 10.1186/1742-4690-5-118 10.1093/embo-reports/kve141 10.1186/1742-4690-5-117 10.1016/j.molcel.2009.06.003 10.1186/1742-4690-6-26 10.1097/qad.0000000000001938 10.1038/ncomms8562 10.1038/ni1352 10.1186/1742-4690-1-44 10.1128/jvi.01390-07 10.1038/nmeth746 10.1097/QAD.0b013e328352adca 10.1093/nar/gkn076 10.1007/s13365-011-0046-1 10.1186/1742-4690-6-18 10.7717/peerj.9994 10.1161/01.res.87.5.e1 10.1016/j.cell.2020.02.052 10.1152/ajplung.00387.2018 10.1371/journal.pone.0235987 10.11817/j.issn.1672-7347.2018.07.007 10.3233/dma-2011-0766 10.1073/pnas.1019055108 10.4331/wjbc.v5.i4.437 10.1186/s12879-015-0878-z 10.1042/bsr20194433 10.1002/jcla.23590
Current Hypertension Reports; Abel T, Moodley J et. al.

Apr 13th, 2021 - This review investigated the potential role of microRNAs (miRNAs) in the synergy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, preeclampsia (PE), and human immunodeficiency virus (HIV) infection. Maternal health is a g...

Prevalence and risk factors for obesity among elderly patients living with HIV/AIDS in ...
https://doi.org/10.1097/MD.0000000000025399
Medicine Dakum P, Avong YK et. al.

Apr 13th, 2021 - Obesity is associated with detrimental changes in cardiovascular and metabolic parameters, including blood pressure, dyslipidemia, markers of systemic inflammation, and insulin resistance. In the elderly living with the human immunodeficiency viru...

Safety of Tenofovir Disoproxil Fumarate (TDF) for Pregnant Women facing the COVID-19 Pa...
https://doi.org/10.1093/aje/kwab109
American Journal of Epidemiology; Hernandez-Diaz S, Bateman BT et. al.

Apr 13th, 2021 - We assessed the teratogenicity of tenofovir, a human immunodeficiency virus (HIV) drug similar to remdesivir currently being evaluated for the treatment of coronavirus disease 2019 (COVID-19). Using US Medicaid Analytic Extract (MAX) claims data (...

see more →

Guidelines  145 results

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147901
MMWR. Morbidity and Mortality Weekly Report; Tepper NK, Curtis KM et. al.

Apr 9th, 2020 - "U.S. Medical Eligibility Criteria for Contraceptive Use" (U.S. MEC) 2016 provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1). The U.S. MEC is adapted f...

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
https://www.nejm.org/doi/full/10.1056/NEJMoa1909953
The New England Journal of Medicine; Tait,D.,et al

Oct 28th, 2019 - BACKGROUND Results of an earlier analysis of a trial of the M72/AS01E candidate vaccine against Mycobacterium tuberculosis showed that in infected adults, the vaccine provided 54.0% protection against active pulmonary tuberculosis disease, without...

Association between pubic hair grooming and prevalent sexually transmitted infection among female university students
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0221303
PLOS One; Luster,J.,et al

Sep 3rd, 2019 - Recent findings have suggested an association between pubic hair grooming and self-reported history of sexually transmitted infection (STI), specifically gonococcal infection (GC), chlamydial infection (CT), or human immunodeficiency virus (HIV). ...

Obesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination Survey
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504569/

Jul 12th, 2019 - Our objective was to compare obesity prevalence among human immunodeficiency virus (HIV)-infected adults receiving care and the U.S. general population and identify obesity correlates among HIV-infected men and women. Cross-sectional data was col...

HIV Infection and AIDS Differential Diagnoses
https://emedicine.medscape.com/article/211316-differential

Jun 30th, 2019 - Human immunodeficiency virus (HIV) infection should be considered in any patient with unusual or recurrent serious infections without another cause, especially in those with risk factors for HIV infection.

see more →

Drugs  675 results see all →

Clinicaltrials.gov  52,843 results

Seroprevalence and trends of transfusion transmissible infections among retrospective b...
https://doi.org/10.1016/j.transci.2021.103132
Transfusion and Apheresis Science : Official Journal of T... Emadi B, Ghahraman Rezaieh M et. al.

Apr 13th, 2021 - Transfusion transmissible infections (TTIs) have been a public health challenge for the accessibility, quality and safety of blood transfusion. The present study aimed to consider the prevalence and the trends of hepatitis B virus (HBV), hepatitis...

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV...
https://doi.org/10.1080/22221751.2021.1917309
Emerging Microbes & Infections; Yu D, Zhu Y et. al.

Apr 13th, 2021 - EK1 peptide is a membrane fusion inhibitor with broad-spectrum activity against human coronaviruses (CoVs). In the outbreak of COVID-19, we generated a lipopeptide EK1V1 by modifying EK1 with cholesterol, which exhibited significantly improved ant...

The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preec...
https://doi.org/10.1007/s11906-021-01138-5 10.1007/s10096-020-03899-4 10.1038/s41591-020-0820-9 10.1002/jmv.25732 10.1016/j.hlc.2014.01.001 10.1038/nrg2290 10.1016/j.cell.2007.12.024 10.1152/physrev.00041.2015 10.1177/0300985813502820 10.1038/nm1639 10.1161/01.Hyp.0000060689.38912.Cb 10.1186/gb-2007-8-2-r27 10.1002/path.2162 10.1016/j.bpobgyn.2011.01.006 10.7189/jogh.08.020401 10.1161/hypertensionaha.117.10803 10.1016/S0140-6736(05)17987-2 10.1146/annurev-pathol-121808-102149 10.1155/2018/8724549 10.1002/ijgo.12038 10.1016/j.ejogrb.2004.04.014 10.1016/j.jri.2007.04.005 10.5830/cvja-2012-078 10.1038/s41564-020-0688-y 10.1002/cbic.202000047 10.1016/j.cmi.2020.04.010 10.1016/j.scitotenv.2020.141364 10.1001/jama.2020.1585 10.1128/jvi.00127-20 10.1016/j.molcel.2020.04.022 10.1038/s41467-020-15562-9 10.1056/NEJMoa1910993 10.1042/cs20200163 10.29252/rbmb.9.1.97 10.3389/fendo.2013.00166 10.1002/cphy.c130040 10.1016/j.biochi.2020.04.008 10.1161/circresaha.116.307708 10.1016/j.placenta.2011.09.020 10.1016/j.placenta.2010.01.006 10.1210/jcem.87.4.8422 10.1016/j.placenta.2005.02.015 10.1152/ajprenal.00410.2003 10.1139/y87-391 10.1172/jci107462 10.1385/endo:18:3:239 10.1385/endo:16:2:117 10.1038/s41371-018-0113-7 10.1161/circresaha.118.313276 10.1056/NEJMoa055352 10.3389/fmed.2019.00010 10.1016/S0021-9258(18)41732-2 10.1016/j.ajog.2015.08.003 10.1002/pd.2660 10.1016/j.drudis.2018.01.048 10.1007/s10815-018-1326-y 10.1172/jci22991 10.1016/j.ebiom.2015.09.003 10.1016/j.fertnstert.2014.01.058 10.5935/1518-0557.20160039 10.1095/biolreprod.113.116590 10.1038/srep40001 10.1371/journal.pone.0041080 10.1161/circresaha.118.313276 10.1186/1471-2164-8-166 10.1373/clinchem.2010.147660 10.1093/molehr/gaz010 10.1017/s204017441900014x 10.1161/CIRCULATIONAHA.111.054361 10.1016/j.ajpath.2011.04.035 10.1038/cmi.2014.45 10.1016/j.bbcan.2009.09.005 10.1161/circresaha.108.191270 10.1096/fj.09-149724 10.1016/j.ejmhg.2015.03.006 10.6515/acs20170221b 10.1371/journal.pone.0084188 10.1016/j.cjca.2014.12.026 10.1161/hypertensionaha.111.203489 10.1042/cs20120121 10.1038/srep19910 10.1016/j.devcel.2008.07.008 10.1161/01.Res.0000265065.26744.17 10.1371/journal.pone.0090020 10.3892/mmr.2014.2214 10.1161/hypertensionaha.112.197301 10.1016/j.placenta.2012.07.012 10.3389/fcvm.2017.00060 10.1111/j.1582-4934.2011.01291.x 10.1530/rep-09-0092 10.1152/physiol.00043.2008 10.1177/0300060514540627 10.1111/febs.12037 10.1210/jc.2011-3131 10.1210/jc.2017-00672 10.1016/s0140-6736(15)00070-7 10.1371/journal.pone.0170063 10.1016/s0140-6736(02)11195-0 10.1016/j.jinf.2013.12.018 10.1097/01.aids.0000198090.70325.bd 10.3389/fimmu.2019.03079 10.1007/s11262-017-1443-1 10.1186/s12985-019-1128-6 10.1128/jvi.05065-11 10.1371/journal.ppat.1000263 10.1186/1742-4690-5-118 10.1093/embo-reports/kve141 10.1186/1742-4690-5-117 10.1016/j.molcel.2009.06.003 10.1186/1742-4690-6-26 10.1097/qad.0000000000001938 10.1038/ncomms8562 10.1038/ni1352 10.1186/1742-4690-1-44 10.1128/jvi.01390-07 10.1038/nmeth746 10.1097/QAD.0b013e328352adca 10.1093/nar/gkn076 10.1007/s13365-011-0046-1 10.1186/1742-4690-6-18 10.7717/peerj.9994 10.1161/01.res.87.5.e1 10.1016/j.cell.2020.02.052 10.1152/ajplung.00387.2018 10.1371/journal.pone.0235987 10.11817/j.issn.1672-7347.2018.07.007 10.3233/dma-2011-0766 10.1073/pnas.1019055108 10.4331/wjbc.v5.i4.437 10.1186/s12879-015-0878-z 10.1042/bsr20194433 10.1002/jcla.23590
Current Hypertension Reports; Abel T, Moodley J et. al.

Apr 13th, 2021 - This review investigated the potential role of microRNAs (miRNAs) in the synergy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, preeclampsia (PE), and human immunodeficiency virus (HIV) infection. Maternal health is a g...

Prevalence and risk factors for obesity among elderly patients living with HIV/AIDS in ...
https://doi.org/10.1097/MD.0000000000025399
Medicine Dakum P, Avong YK et. al.

Apr 13th, 2021 - Obesity is associated with detrimental changes in cardiovascular and metabolic parameters, including blood pressure, dyslipidemia, markers of systemic inflammation, and insulin resistance. In the elderly living with the human immunodeficiency viru...

Safety of Tenofovir Disoproxil Fumarate (TDF) for Pregnant Women facing the COVID-19 Pa...
https://doi.org/10.1093/aje/kwab109
American Journal of Epidemiology; Hernandez-Diaz S, Bateman BT et. al.

Apr 13th, 2021 - We assessed the teratogenicity of tenofovir, a human immunodeficiency virus (HIV) drug similar to remdesivir currently being evaluated for the treatment of coronavirus disease 2019 (COVID-19). Using US Medicaid Analytic Extract (MAX) claims data (...

see more →

News  895 results

Fast Five Quiz: HIV Pre-exposure Prophylaxis: Selecting Appropriate Candidates
https://reference.medscape.com/viewarticle/924385

Jan 19th, 2021 - Human immunodeficiency virus (HIV) continues to be a major public health problem worldwide. At the end of 2019, an estimated 38 million individuals were living with HIV. Owing to gaps in HIV services, 1.7 million people were newly infected with HI...

COVID-19 Outcomes in Patients With Immunodeficiency
https://www.medscape.com/viewarticle/943484

Jan 3rd, 2021 - Adults with primary immunodeficiency (PID) and symptomatic secondary immunodeficiency (SID) are at risk of greater morbidity and mortality from COVID-19 compared with the general population, a new study suggests. The findings were published in the...

Immunodeficiency Strongly Linked to Mental Illness, Suicidal Behavior
https://www.medscape.com/viewarticle/941482

Nov 22nd, 2020 - Patients with a primary humoral immunodeficiency (PID) are 91% more likely to have a psychiatric disorder and 84% more likely to exhibit suicidal behavior, compared against those without the condition, new research shows. Results showed that this ...

COVID-19 Outcomes Vary Widely in Patients With Primary Immunodeficiencies
https://www.staging.medscape.com/viewarticle/939374

Oct 19th, 2020 - NEW YORK (Reuters Health) - Clinical outcomes of COVID-19 in patients with primary immunodeficiency diseases range from mild illness to death, according to a small case series. "We were first surprised that we had only a few cases considering how ...

COVID-19 Outcomes Vary Widely in Patients With Primary Immunodeficiencies
https://www.medscape.com/viewarticle/939374

Oct 19th, 2020 - NEW YORK (Reuters Health) - Clinical outcomes of COVID-19 in patients with primary immunodeficiency diseases range from mild illness to death, according to a small case series. "We were first surprised that we had only a few cases considering how ...

see more →

Patient Education  41 results see all →